1075 Participants Needed

PC CARES for Suicide Prevention

Recruiting at 1 trial location
MM
LW
Overseen ByLisa Wexler, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: University of Michigan
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

This participatory, pragmatic efficacy-implementation trial evaluates the impact of Promoting Community Conversations About Research to End Suicide (PC CARES) to evaluate Learning Circle (LC) participant outcomes (AIM#1), community-wide diffusion effects, and efficacy by tracking youth impact (AIM#2), while finding sustainable ways to scale PC CARES to other Alaska Native (AN) communities (AIM#3).

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is PC CARES for Suicide Prevention safe for humans?

There is limited information on the safety of PC CARES for Suicide Prevention, as adverse events in suicide prevention trials are often underreported and inconsistently defined. However, using multiple methods like structured telephone follow-ups can improve the detection of adverse events, which is important for understanding safety in such interventions.12345

What makes the PC CARES treatment unique for suicide prevention?

PC CARES is unique because it focuses on promoting community conversations to address suicide prevention, which is different from traditional treatments that often focus on individual therapy or medication. This approach emphasizes community engagement and dialogue to create a supportive environment for individuals at risk.678910

Research Team

LW

Lisa Wexler, PhD

Principal Investigator

Univer

Eligibility Criteria

This trial is for individuals in rural Alaska communities involved in or affected by suicide. It aims to include a broad range of participants without specific health-related inclusion or exclusion criteria listed.

Inclusion Criteria

I am 12 years or older and live or work in the specified area.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

PC CARES Intervention

Participants attend 1-5 sessions of the PC CARES curriculum, either virtually or in-person, focusing on suicide prevention and community engagement.

5 months
Monthly sessions

Community-Wide Data Collection

Data is collected from community members to assess the diffusion of learning and community-level changes.

5 months
Monthly data collection

Follow-up

Participants are monitored for changes in suicide prevention behaviors and community engagement.

6 months
1 month and 6 months follow-up visits

Treatment Details

Interventions

  • Promoting Community Conversations About Research to End Suicide
Trial Overview The study tests the PC CARES program, which uses Learning Circles to encourage community discussions on suicide prevention. The goal is to see if this approach helps participants, spreads awareness community-wide, and can be sustainably expanded.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: PC CARES InterventionExperimental Treatment1 Intervention
PC CARES Intervention Participants will attend 1-5 sessions of the PC CARES curriculum, either virtually or in-person. Investigators will collect data from this group at baseline, after each session they attend, and at follow-up.
Group II: No InterventionActive Control1 Intervention
This group will not attend the PC CARES sessions. Investigators will collect data from adults and youth at baseline, at 5 monthly timepoints as learning circles are being conducted in the community, and at follow-up (after 1 month and 6 months).

Promoting Community Conversations About Research to End Suicide is already approved in United States for the following indications:

🇺🇸
Approved in United States as PC CARES for:
  • Suicide prevention in rural Alaska Native communities

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Michigan

Lead Sponsor

Trials
1,891
Recruited
6,458,000+

Norton Sound Health Corporation

Collaborator

Trials
5
Recruited
4,500+

Maniilaq Association

Collaborator

Trials
2
Recruited
1,200+

National Institute of Mental Health (NIMH)

Collaborator

Trials
3,007
Recruited
2,852,000+

Yukon Kuskokwim Health Corporation

Collaborator

Trials
6
Recruited
5,600+

University of Alaska Fairbanks

Collaborator

Trials
10
Recruited
14,100+

Findings from Research

A qualitative study involving experienced suicide researchers revealed significant challenges in defining and reporting adverse events (AEs) and serious adverse events (SAEs) in suicide prevention trials, which complicates safety evaluations.
Participants emphasized the urgent need for clear and consistent definitions and reporting standards for AEs and SAEs to improve the comparability of studies and enhance safety monitoring in at-risk populations.
Variability in the definition and reporting of adverse events in suicide prevention trials: an examination of the issues and a proposed solution.Oquendo, MA., Feldman, S., Silverman, E., et al.[2022]
In the ED-SAFE study, structured telephone follow-up assessments were crucial for identifying adverse events (AEs), detecting 45% of total AEs that were missed by chart reviews alone.
The detection of suicide attempts varied significantly by method, with structured follow-ups identifying 59% of attempts compared to only 18% through chart reviews, highlighting the importance of using multiple detection methods in suicide research.
Using structured telephone follow-up assessments to improve suicide-related adverse event detection.Arias, SA., Zhang, Z., Hillerns, C., et al.[2021]
In a study involving 1329 patients from primary care settings in Australia and England, 5.3% reported safety incidents over the past year, with the most common issues being delays in accessing care and problems with diagnosis and assessment.
The study highlighted that patient-reported incidents often differ from those reported by staff, underscoring the importance of including patient perspectives to improve safety and service quality in primary care.
Nature and type of patient-reported safety incidents in primary care: cross-sectional survey of patients from Australia and England.Hernan, AL., Giles, SJ., Carson-Stevens, A., et al.[2023]

References

Variability in the definition and reporting of adverse events in suicide prevention trials: an examination of the issues and a proposed solution. [2022]
Using structured telephone follow-up assessments to improve suicide-related adverse event detection. [2021]
Nature and type of patient-reported safety incidents in primary care: cross-sectional survey of patients from Australia and England. [2023]
Involving Patients and Families in the Analysis of Suicides, Suicide Attempts, and Other Sentinel Events in Mental Healthcare: A Qualitative Study in The Netherlands. [2023]
Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting. [2020]
Palliative care program uses self-assessment tool. [2010]
Developing and Testing the Feasibility of a Culturally Based Tele-Palliative Care Consult Based on the Cultural Values and Preferences of Southern, Rural African American and White Community Members: A Program by and for the Community. [2020]
The impact of a palliative care program in a rural Appalachian community hospital: a quality improvement process. [2019]
Place and provision of palliative care for children with progressive cancer: a study by the Paediatric Oncology Nurses' Forum/United Kingdom Children's Cancer Study Group Palliative Care Working Group. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
How does community engagement evolve in different compassionate community contexts? A longitudinal comparative ethnographic research protocol. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security